Cupid acquires land parcel near Mumbai
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Subscribe To Our Newsletter & Stay Updated